Trial Profile
An observational study evaluating the effect of dose optimization on trough levels in cancer patients treated with imatinib, sunitinib and pazopanib.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 30 Nov 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress